Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Praxis Precision Medicines granted 2,754 restricted stock units to 13 new non-executive employees. The awards were issued under the 2024 Inducement Plan as required by Nasdaq Listing Rule 5635(c)(4) for new hires.
Key figures
- Shares granted
- 2754
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.